| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/28/2004 | EP1440157A1 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440084A2 Sperm factor sequences |
| 07/28/2004 | EP1265912A4 Mass1 gene, a target for anticonvulsant drug development |
| 07/28/2004 | EP1175445B1 Specific antibodies and antibody fragments for tgfbeta1 |
| 07/28/2004 | EP1047781B1 Il-18 receptors |
| 07/28/2004 | EP0941311B1 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |
| 07/28/2004 | EP0935607B1 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 07/28/2004 | EP0920509B1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 07/28/2004 | EP0728214B1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
| 07/28/2004 | EP0584214B1 Gene manipulation and expression using genomic elements |
| 07/28/2004 | EP0452484B2 Production of proteins using homologous recombination |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516738A Acetylation of GP41 framgnets |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515591A Growth hormone and serum albumni recombinant fusion protein |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159450C Low oxygen affinity mutant hemoglobin |
| 07/28/2004 | CN1159440C Mutants of Rb and p53 genes and uses thereof |
| 07/28/2004 | CN1159439C Pantropic neurotrophic factors |
| 07/27/2004 | US6767997 Antibodies that bind deoxyribonuclease IIβ enzyme proteins |
| 07/27/2004 | US6767996 Altered antibodies and their preparation |
| 07/27/2004 | US6767990 Peptides used as angiotensin converting enzyme inhibitor and preparation process thereof |
| 07/27/2004 | US6767727 For treatment of genetic disorders; targets for competitive binding assays; drug screening |
| 07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 07/27/2004 | CA2279999C The neurotrophic factor nnt-1 |
| 07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 07/22/2004 | WO2004061077A2 Increasing gamete production with a gene switch |
| 07/22/2004 | WO2004060919A1 Agonist antibody against heteroreceptor |
| 07/22/2004 | WO2004060909A2 Increasing production of proteins in gram-positive microorganisms |
| 07/22/2004 | WO2004060869A2 Methods and compositions for catalytic dna exchange in a sequence manner |
| 07/22/2004 | WO2004060145A2 Isolation and identification of cross-reactive t cells |
| 07/22/2004 | WO2004060053A2 Transgenic mice expressing human cd20 |
| 07/22/2004 | WO2004060052A2 Transgenic mice expressing human cd20 and/or cd16 |
| 07/22/2004 | WO2004027049B1 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004019860A3 Formulations of modified antibodies and methods of making the same |
| 07/22/2004 | WO2004015391A9 Mass spectrometry-based identification of proteins |
| 07/22/2004 | WO2003073350A8 Method and analytical system for identifying targets in a signaling network |
| 07/22/2004 | WO2003028668A3 Gammaglobulin treatment of immune disorders |
| 07/22/2004 | WO2003022869A3 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 07/22/2004 | WO2003018605A3 Solid-phase synthesis of oligosaccharides and glycopeptides using glycosynthases |
| 07/22/2004 | WO2002074239A3 Compositions and methods for the treatment and clinical remission of psoriasis |
| 07/22/2004 | WO2002059281A3 High level cytokine production with enhanced cell viability |
| 07/22/2004 | US20040143859 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040143857 Erythropoietin analog-human serum albumin fusion |
| 07/22/2004 | US20040143102 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 07/22/2004 | US20040143095 for treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety; angiogenesis inhibitors; genetic engineering |
| 07/22/2004 | US20040142866 Derivatives of the insulinotropic peptide exendin-4 and methods of production thereof |
| 07/22/2004 | US20040142478 Expression vector comprising saccharomyces regulatory sequences for controlling heterologous and homologous gene expression; genetic engineering protein translation |
| 07/22/2004 | US20040142477 Expression vector comprising antisense or inhibitory RNA sequences for use in increasing phyotene concentration in plants; tissue engineering |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 07/22/2004 | US20040142448 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 07/22/2004 | US20040142441 Comprises polypeptide with lipolytic activities for in enhancing the processing of fats |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142430 Production of a multimeric protein by cell fusion method |
| 07/22/2004 | US20040142429 Using nickel-chelate chromatography to purifiy and recover hydrophobic proteins, polypeptides or peptides in non-aggregated form; lipid bilayer formation |
| 07/22/2004 | US20040142427 Nucleotide sequences coding lyase for use as tool in identifying treatments which prevent or inhibit tumor cell metastasis, inflammation and autoimmunity |
| 07/22/2004 | US20040142426 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040142423 Novel polypeptides, DNAs encoding the same and use thereof |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142418 Novel neurotrophic factors |
| 07/22/2004 | US20040142417 Receptor proteins |
| 07/22/2004 | US20040142400 High affinity monoclonal antibody for recognizing the estrogen receptor (ER) and method for creating the antibody |
| 07/22/2004 | US20040142399 Recombinant FlaA as a diagnostic reagent |
| 07/22/2004 | US20040142385 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 07/22/2004 | US20040142376 Deoxyribonuclease IIbeta proteins and cDNAs |
| 07/22/2004 | US20040142320 use of cells capable or carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome for diagnosis/drug screening; antibiotic resistance |
| 07/22/2004 | US20040141998 antigen is targeted to the receptor of the antigen-presenting cell, in some instances without being blocked by the natural ligand for the surface receptor; molecular complexes including the binding agent coupled to an antigen. |
| 07/22/2004 | US20040141982 Use of genetically engineered antibodies to treat multiple myeloma |
| 07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
| 07/22/2004 | US20040141965 Immunohistochemistry; diagnosis of human breast cancer |
| 07/22/2004 | US20040141959 Somatic cells with ablated PrP gene and methods of use |
| 07/22/2004 | US20040141918 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | DE10260805A1 Verfahren und Vorrichtung zum Optimieren einer Nucleotidsequenz zur Expression eines Proteins Method and apparatus for optimizing a nucleotide sequence for expressing a protein |
| 07/22/2004 | CA2507882A1 Transgenic mice expressing human cd20 |
| 07/22/2004 | CA2507880A1 Transgenic mice expressing human cd20 and/or cd16 |
| 07/22/2004 | CA2507307A1 Increased production of secg protein in bacillus subtilis |
| 07/21/2004 | EP1439230A2 Human transmembrane protein TMP-2 gene |
| 07/21/2004 | EP1439229A2 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 07/21/2004 | EP1439226A2 A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity |
| 07/21/2004 | EP1439193A2 Antibody directed to polypeptide having heparanase activity |
| 07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
| 07/21/2004 | EP1439188A1 Search for cancer marker by novel screening method |
| 07/21/2004 | EP1438584A1 Target assisted iterative screening (tais) : a novel screening format for large molecular repertoires |
| 07/21/2004 | EP1438434A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 07/21/2004 | EP1438425A2 69583 and 85924,novel human protein kinase family members and uses therefor |
| 07/21/2004 | EP1438411A2 Use of aminoglycoside resistance gene |
| 07/21/2004 | EP1438400A1 Multi-chain eukaryotic display vectors and uses thereof |
| 07/21/2004 | EP1438388A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 07/21/2004 | EP1438387A2 Methods of making glycomolecules with enhanced activities and uses thereof |
| 07/21/2004 | EP1438386A2 Transmembrane protein differentially expressed in cancer |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438340A2 Antibodies against kdr, their production and uses |
| 07/21/2004 | EP1438339A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 07/21/2004 | EP1438338A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 07/21/2004 | EP1438336A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicinaments |